Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.
Kestrel Therapeutics has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.
Kestrel Therapeutics's investors include Sante Ventures, Pfizer Venture Investments.
Kestrel Therapeutics is headquartered in Allston, United States.
Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.
Kestrel Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kestrel Therapeutics — Funding & Investors." VCBacked, December 1, 2021, https://www.vcbacked.co/company/kestrel-therapeutics. Accessed September 30, 2026.
VCBacked. (2021). Kestrel Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/kestrel-therapeutics
{{cite web |title=Kestrel Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kestrel-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated